We use cookies to ensure that we give you the best experience on our website Learn more

May 30, 2018

ESPID 2018

02 / WHAT IS THE VALUE OF BUDGET IMPACT MODELS IN VACCINE DECISION MAKING? THE CASE OF PEDIATRIC HEXAVALENT VACCINES IN EUROPE

;

Wolfson, L.;

Dijk, B.V.;

Heisen, M.;

Lu, X.I.

pediatric vaccination

health economics

evidence based decision making

hexavalent vaccines

thumbnail

Keywords

pediatric vaccination

health economics

evidence based decision making

hexavalent vaccines

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.